Solanesol Improves Diabetes-Associated Cognitive Dysfunction in Mice Alongside Metabolic, Hippocampal and Gut-Related Changes
Nutrients · 11.11.2026 · 18 (22) · 3739
DOI: 10.3390/nu18223739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 11.11.2026. Verfasst von Zhaoming Cao und 9 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Life Science Academy.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Diabetes-associated cognitive dysfunction (DACD) remains difficult to treat, and improved peripheral metabolism does not necessarily restore cognition. We investigated solanesol, a plant-derived long-chain polyisoprenoid alcohol, in a high-fat-diet (HFD) mouse model.
Methods
Male C57BL/6 mice received an HFD for 24 weeks, followed by 6 weeks of solanesol (10, 20 or 30 mg/kg/day) or rosiglitazone (20 mg/kg/day). Metabolic indices, Morris water maze and novel object recognition performance, hippocampal and ileal morphology, hippocampal transcriptomics, faecal metagenomics and untargeted metabolomics were assessed.
Results
HFD feeding induced obesity, hyperglycaemia, hyperinsulinaemia, insulin resistance and impaired spatial and recognition memory. Rosiglitazone improved insulin sensitivity without a detectable cognitive benefit. Solanesol reduced HOMA-IR at all tested doses; reductions in body weight and fasting glucose were observed at the highest dose (SNL-30). Cognitive responses differed by endpoint and were most consistent at the medium and high doses. SNL-30 was associated with a qualitative improvement in hippocampal and ileal morphology, increased hippocampal Apoc3 and Pon1 expression and changes in the gut microbiota and faecal metabolome. Faecal microbial and metabolite profiles covaried.
Conclusions
Solanesol improved metabolic and selected cognitive outcomes in HFD-fed mice, with the broadest response at the highest tested dose. Solanesol is a candidate for further preclinical study in DACD.
Förderung
- Beijing Life Science Academy
Zitieren
APA
Cao, Z., Wang, Z., Tian, D., Ma, Y., Zhu, C., Li, X., Fu, Y., Chen, H., Hou, H., & Chu, M. (2026). Solanesol Improves Diabetes-Associated Cognitive Dysfunction in Mice Alongside Metabolic, Hippocampal and Gut-Related Changes. Nutrients, 18(22), 3739. https://doi.org/10.3390/nu18223739
Vancouver
Cao Z, Wang Z, Tian D, Ma Y, Zhu C, Li X, et al. Solanesol Improves Diabetes-Associated Cognitive Dysfunction in Mice Alongside Metabolic, Hippocampal and Gut-Related Changes. Nutrients. 2026;18(22):3739. doi:10.3390/nu18223739
BibTeX
@article{Cao2026,
author = {Cao, Zhaoming and Wang, Ziyuan and Tian, Daizhao and Ma, Yinchao and Zhu, Can and Li, Xin and Fu, Yaning and Chen, Huan and Hou, Hongwei and Chu, Ming},
title = {Solanesol Improves Diabetes-Associated Cognitive Dysfunction in Mice Alongside Metabolic, Hippocampal and Gut-Related Changes},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {22},
pages = {3739},
doi = {10.3390/nu18223739}
}
EUVIMED